Infectious Bovine Rhinotracheitis Post-Eradication Program in the Autonomous Province of Bolzano, Italy: A Retrospective Study on Potential Bovine Herpesvirus Type 2 Cross-Reactivity.
BoAHV1
BoAHV2
IBR
bulk milk serology
Journal
Animals : an open access journal from MDPI
ISSN: 2076-2615
Titre abrégé: Animals (Basel)
Pays: Switzerland
ID NLM: 101635614
Informations de publication
Date de publication:
13 Nov 2023
13 Nov 2023
Historique:
received:
27
09
2023
revised:
06
11
2023
accepted:
07
11
2023
medline:
25
11
2023
pubmed:
25
11
2023
entrez:
25
11
2023
Statut:
epublish
Résumé
Bovine alphaherpesviruses, BoAHV, can cause respiratory, genital and neurological disorders. In particular, bovine alphaherpesvirus type 1 (BoAHV1) is one of the most significant ruminant pathogens worldwide and it can heavily damage the livestock industry. BoAHV1 can cause infectious bovine rhinotracheitis (IBR) along with fertility disorders. Bovine alphaherpesvirus type 2 (BoAHV2) can cause two different conditions as well: pseudo-lumpy skin disease (PSLD) and bovine herpetic mammillitis (BHM). The autonomous province of Bolzano (Italy) has adopted several strategies to control and eradicate IBR, and it was declared in 2000 to be IBR-free by the European Commission. Since 2001, a post-eradication monitoring program has overseen the serological analysis of bulk milk and, in the presence of a positive result, a follow-up examination is performed on the individual blood serum of all bovines older than 24 months that belong to bulk milk-positive herds. Despite the detection of positives in both bulk milk and serum samples, South Tyrol has been declared IBR-free, as these positives have never been confirmed through seroneutralization. Between 2014 and 2022, approximately 41,000 bulk milk (averaging 4300 samples/year) and 3229 serum samples were tested for BoAHV1. The aim of this study was to evaluate the post-eradication program for IBR with a particular focus on the potential cross-reactivity with BoAHV2; for this reason, serum samples were also tested for BoAHV2 antibodies. This study could be of great importance for those countries that submit herds to an IBR monitoring and eradication program; performing further analyses to confirm and explain false positive outcomes would increase the reliability of the obtained results.
Identifiants
pubmed: 38003120
pii: ani13223502
doi: 10.3390/ani13223502
pmc: PMC10668675
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Front Vet Sci. 2020 Oct 28;7:587885
pubmed: 33195619
Anim Health Res Rev. 2021 Dec;22(2):136-146
pubmed: 35076360
Vet Microbiol. 1984 Aug;9(4):329-44
pubmed: 6208673
Vet Microbiol. 2002 Aug 2;88(1):27-45
pubmed: 12119136
Vet Microbiol. 2006 Mar 31;113(3-4):293-302
pubmed: 16337098
Vet Res. 2007 Mar-Apr;38(2):181-209
pubmed: 17257569
Vet Microbiol. 2018 Jun;219:150-153
pubmed: 29778188
J Immunol. 2016 Mar 1;196(5):2205-2218
pubmed: 26810224
Prev Vet Med. 2019 Nov 1;171:104743
pubmed: 31476591
Vet Microbiol. 2012 Oct 12;159(3-4):282-90
pubmed: 22578637
Can J Comp Med. 1982 Jul;46(3):225-63
pubmed: 6290011
Front Microbiol. 2022 Aug 04;13:970545
pubmed: 35992696
Res Vet Sci. 2009 Aug;87(1):161-6
pubmed: 19157471
BMC Vet Res. 2020 Mar 30;16(1):103
pubmed: 32228616
Arch Virol. 2021 Feb;166(2):639-643
pubmed: 33315144
Vet J. 2014 Sep;201(3):249-56
pubmed: 24954868